Chicago Partners Investment Group LLC Acquires New Shares in DENTSPLY SIRONA Inc. $XRAY

Chicago Partners Investment Group LLC acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 16,462 shares of the medical instruments supplier’s stock, valued at approximately $277,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new position in DENTSPLY SIRONA in the 1st quarter valued at approximately $25,000. Brooklyn Investment Group bought a new position in DENTSPLY SIRONA in the 1st quarter valued at approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at $26,000. Trust Co. of Toledo NA OH bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $27,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of DENTSPLY SIRONA by 8,003.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 2,241 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $13.11 on Friday. DENTSPLY SIRONA Inc. has a one year low of $11.69 and a one year high of $24.86. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The stock has a market cap of $2.62 billion, a P/E ratio of -2.77, a P/E/G ratio of 0.83 and a beta of 0.96. The stock’s fifty day moving average is $13.35 and its 200 day moving average is $14.50.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the prior year, the business posted $0.49 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 10th. Shareholders of record on Friday, September 26th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on XRAY. UBS Group lowered their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Evercore ISI lowered their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Stifel Nicolaus lowered their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Finally, Barrington Research decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $18.00.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.